TABLE 3.
Risk of Dystonia Across All Trials
| Treatment | N | Dystonic Events | Risk of Dystonia |
|---|---|---|---|
| Haloperidol | 844 | 40 | 4.7% |
| Haloperidol + Promethazine | 560 | 0 | 0% |
| SGAs | 2021 | 12 | 0.6% |
Risk of Dystonia Across All Trials
| Treatment | N | Dystonic Events | Risk of Dystonia |
|---|---|---|---|
| Haloperidol | 844 | 40 | 4.7% |
| Haloperidol + Promethazine | 560 | 0 | 0% |
| SGAs | 2021 | 12 | 0.6% |